Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
- PMID: 35522033
- PMCID: PMC9210515
- DOI: 10.2337/dc21-2643
Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
Abstract
Objective: To find a carbohydrate (CHO) tolerance threshold for unannounced snacks to avoid the 2 h increase in glycemia (difference between pre- and postmeal blood glucose [ΔBG]) ≥50 mg/dL in advanced hybrid closed-loop (a-HCL) users.
Research design and methods: Fourteen children and adolescents with type 1 diabetes (7 females; mean age [± SD] 14.5 ± 3.6 years), users of the Medtronic MiniMed 780G, participated in the study. For 12 days, they did not perform insulin bolus before breakfasts, with defined different quantities and types of CHO, with or without fats, performing blood glucose (BG) before and 2 h after the meal.
Results: A cutoff of 19.8 g of total CHO was found to determine a ΔBG of 50 mg/dL. BG never exceeded 250 mg/dL. Mean time in range was ≥70% in the 2 h following each snack.
Conclusions: Unannounced snacks of up to 20 g of CHO can avoid ΔBG ≥50 mg/dL in MiniMed 780G users, although unannounced meals of up to 30 g of CHO are safe.
© 2022 by the American Diabetes Association.
Figures
Similar articles
-
Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control.Diabetes Care. 2023 Mar 1;46(3):544-550. doi: 10.2337/dc22-1692. Diabetes Care. 2023. PMID: 36598841 Free PMC article. Clinical Trial.
-
Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.Diabetes Technol Ther. 2023 Sep;25(9):579-588. doi: 10.1089/dia.2023.0139. Diabetes Technol Ther. 2023. PMID: 37335759 Clinical Trial.
-
Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system.Acta Diabetol. 2022 May;59(5):743-746. doi: 10.1007/s00592-022-01851-w. Epub 2022 Jan 24. Acta Diabetol. 2022. PMID: 35072781 No abstract available.
-
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.Diabetes Technol Ther. 2024 Mar;26(S3):76-83. doi: 10.1089/dia.2023.0429. Diabetes Technol Ther. 2024. PMID: 38377327 Free PMC article. Clinical Trial.
-
MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy.Expert Rev Med Devices. 2021 Jun;18(6):499-504. doi: 10.1080/17434440.2021.1926984. Epub 2021 May 31. Expert Rev Med Devices. 2021. PMID: 34014794 Review.
Cited by
-
Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents With Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed Loop System: A Randomized Controlled Trial Comparing Glucose Control.Diabetes Care. 2023 Mar 1;46(3):544-550. doi: 10.2337/dc22-1692. Diabetes Care. 2023. PMID: 36598841 Free PMC article. Clinical Trial.
-
Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study.Diabetes Technol Ther. 2024 Dec;26(12):897-907. doi: 10.1089/dia.2024.0022. Epub 2024 Jun 24. Diabetes Technol Ther. 2024. PMID: 38805311
-
Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023.Life (Basel). 2023 Mar 14;13(3):783. doi: 10.3390/life13030783. Life (Basel). 2023. PMID: 36983941 Free PMC article. Review.
-
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study.Front Endocrinol (Lausanne). 2024 Jun 20;15:1347141. doi: 10.3389/fendo.2024.1347141. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38966218 Free PMC article.
-
Education Practices of Dietitians Across Australia and New Zealand Around the Glycaemic Management of Dietary Fat and Protein in Type 1 Diabetes and the Use of Continuous Glucose Monitoring: A Survey Evaluation.Nutrients. 2025 Mar 22;17(7):1109. doi: 10.3390/nu17071109. Nutrients. 2025. PMID: 40218867 Free PMC article.
References
-
- Collyns OJ, Meier RA, Betts ZL, et al. . Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 2021;44:969–975 - PubMed